NYSE:TEVA - Teva Pharmaceutical Industries Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $10.71
  • Forecasted Upside: 38.97 %
  • Number of Analysts: 8
  • Breakdown:
  • 1 Sell Ratings
  • 5 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
▼ -0.18 (-2.28%)

This chart shows the closing price for TEVA by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Teva Pharmaceutical Industries Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for TEVA and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for TEVA

Analyst Price Target is $10.71
▲ +38.97% Upside Potential
This price target is based on 8 analysts offering 12 month price targets for Teva Pharmaceutical Industries in the last 3 months. The average price target is $10.71, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 38.97% upside from the last price of $7.71.

This chart shows the closing price for TEVA for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 8 investment analysts is to hold stock in Teva Pharmaceutical Industries. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 12 hold ratings
  • 3 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 11 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 1 buy ratings
  • 9 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 0 buy ratings
  • 7 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 5 hold ratings
  • 1 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 5 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/13/2022UBS GroupInitiated CoverageNeutral$10.00Low
5/17/2022Bank of AmericaUpgradeUnderperform ➝ Neutral$9.00N/A
5/4/2022Piper SandlerDowngradeNeutral ➝ Underweight$11.00 ➝ $7.00Low
4/5/2022BarclaysUpgradeEqual Weight ➝ Overweight$11.00 ➝ $13.00N/A
3/25/2022Sanford C. BernsteinUpgradeMarket Perform ➝ Outperform$11.00Medium
2/18/2022BarclaysLower Price TargetEqual Weight$13.00 ➝ $11.00Medium
1/27/2022ArgusDowngradeBuy ➝ HoldMedium
10/28/2021Raymond JamesDowngradeOutperform ➝ Market PerformHigh
7/29/2021Raymond JamesLower Price TargetOutperform$15.00 ➝ $14.00Medium
7/29/2021Wells Fargo & CompanyLower Price TargetEqual Weight$12.00 ➝ $11.00Medium
5/10/2021UBS GroupReiterated RatingBuy ➝ Neutral$15.00 ➝ $11.00N/A
5/4/2021UBS GroupDowngradeBuy ➝ Neutral$15.00 ➝ $11.00High
3/14/2021JPMorgan Chase & Co.Reiterated RatingHold$10.00Medium
12/28/2020Raymond JamesReiterated RatingBuyN/A
11/24/2020OppenheimerInitiated CoverageMarket PerformLow
11/6/2020BMO Capital MarketsLower Price TargetMarket Perform$13.00 ➝ $11.00High
10/23/2020Raymond JamesReiterated RatingBuyLow
10/13/2020ArgusLower Price TargetAverage ➝ Buy$14.00 ➝ $11.00Low
9/14/2020Raymond JamesReiterated RatingBuyLow
8/26/2020Bank of AmericaReiterated RatingSell$8.00Low
8/6/2020SVB LeerinkBoost Price TargetMarket Perform$13.00 ➝ $14.00Medium
8/6/2020BarclaysUpgradeUnderweight ➝ Equal Weight$10.00 ➝ $13.00Medium
7/27/2020The Goldman Sachs GroupInitiated CoverageNeutral$12.00Low
6/1/2020SunTrust BanksUpgradeHold ➝ Buy$11.00 ➝ $16.00High
5/11/2020UBS GroupBoost Price TargetBuy$12.00 ➝ $15.00Medium
5/8/2020Cantor FitzgeraldReiterated RatingNeutralLow
5/8/2020SVB LeerinkBoost Price TargetMarket Perform$11.00 ➝ $12.00Low
5/8/2020Bank of AmericaReiterated RatingUnderperform$7.00 ➝ $8.00Low
4/24/2020CitigroupInitiated CoverageNeutralLow
4/17/2020BarclaysReiterated RatingSell$9.00Low
4/15/2020Piper SandlerLower Price TargetNeutral$10.00 ➝ $8.00Low
4/6/2020UBS GroupUpgradeNeutral ➝ Buy$14.00 ➝ $12.00High
4/2/2020Morgan StanleyLower Price TargetUnderweight$13.00 ➝ $8.00Medium
3/23/2020Bank of AmericaLower Price TargetUnderperform$11.00 ➝ $7.00Low
3/5/2020Wells Fargo & CompanyBoost Price TargetEqual Weight$10.00 ➝ $12.00Low
2/24/2020Edward JonesDowngradeHold ➝ SellHigh
2/18/2020ArgusBoost Price TargetBuy$10.00 ➝ $15.00Low
2/17/2020UBS GroupBoost Price TargetNeutral$8.00 ➝ $14.00Medium
2/14/2020Morgan StanleyBoost Price TargetUnderweight$8.00 ➝ $13.00High
2/13/2020Bank of AmericaBoost Price TargetUnderperform$8.00 ➝ $11.00High
2/13/2020SunTrust BanksBoost Price TargetHold$9.00 ➝ $13.00Medium
2/13/2020OppenheimerBoost Price TargetOutperform$12.00 ➝ $16.00High
2/12/2020Cantor FitzgeraldBoost Price TargetIn-Line ➝ Neutral$9.00 ➝ $15.00Low
2/12/2020CfraBoost Price TargetHold$11.00 ➝ $13.00Low
1/22/2020Wells Fargo & CompanyBoost Price TargetEqual Weight$8.00 ➝ $10.00Medium
1/3/2020Bank of AmericaUpgradeUnderperform ➝ BuyHigh
11/12/2019JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral$8.00Medium
10/16/2019GabelliUpgradeHold ➝ BuyHigh
9/30/2019Wells Fargo & CompanyLower Price TargetMarket Perform$17.00 ➝ $8.00Low
9/12/2019GuggenheimInitiated CoverageNeutralLow
9/6/2019JPMorgan Chase & Co.Lower Price TargetUnderweight$9.00 ➝ $7.00Low
8/16/2019UBS GroupSet Price TargetHold$8.00High
8/9/2019BMO Capital MarketsLower Price TargetMarket Perform$11.00 ➝ $9.00N/A
8/8/2019Royal Bank of CanadaReiterated RatingHold$10.00High
8/8/2019SunTrust BanksLower Price TargetHold$7.00Medium
8/8/2019Raymond JamesLower Price TargetOutperform$22.00 ➝ $15.00Medium
8/7/2019CowenSet Price TargetHold$9.00Low
7/19/2019Wolfe ResearchInitiated CoveragePeer Perform ➝ Peer Perform$9.00Low
7/15/2019Morgan StanleyDowngradeEqual Weight ➝ Underweight$16.00 ➝ $6.00High
7/10/2019Credit Suisse GroupReiterated RatingNeutralLow
7/5/2019ArgusUpgradeHold ➝ Buy$12.00High
6/18/2019Sanford C. BernsteinLower Price TargetMarket Perform$17.00 ➝ $11.00Medium
6/17/2019MizuhoSet Price TargetHold$11.00Medium
6/17/2019CitigroupSet Price TargetBuy$23.00 ➝ $13.00Low
6/12/2019OppenheimerSet Price TargetBuy$12.00High
6/12/2019Cantor FitzgeraldLower Price TargetNeutral$16.00 ➝ $9.00Low
6/11/2019BarclaysInitiated CoverageUnderweight ➝ Underweight$8.00Medium
6/3/2019CIBCUpgradeMarket Perform ➝ Outperform$12.00Medium
6/3/2019OppenheimerUpgradeMarket Perform ➝ Outperform$12.00Low
5/30/2019Bank of AmericaDowngradeBuy ➝ Underperform$19.00 ➝ $9.00High
5/28/2019Wells Fargo & CompanySet Price TargetHold$17.00Medium
5/28/2019UBS GroupDowngradeBuy ➝ Neutral$22.00 ➝ $12.00High
5/10/2019Wells Fargo & CompanyReiterated RatingHoldHigh
5/9/2019Wells Fargo & CompanyLower Price TargetMarket Perform$18.00 ➝ $17.00Low
5/3/2019Royal Bank of CanadaSet Price TargetHold$19.00Low
5/3/2019BMO Capital MarketsSet Price TargetHold$17.00Low
5/3/2019Morgan StanleySet Price TargetHold$16.00Low
5/3/2019Cantor FitzgeraldBoost Price TargetPositive ➝ Neutral$16.00 ➝ $25.00Medium
5/2/2019Maxim GroupReiterated RatingHoldLow
4/11/2019CitigroupLower Price TargetBuy$27.00 ➝ $23.00Low
4/3/2019Wells Fargo & CompanyLower Price TargetMarket Perform ➝ Market Perform$20.00 ➝ $18.00Low
3/28/2019BMO Capital MarketsInitiated CoverageMarket Perform$18.00Medium
3/19/2019SunTrust BanksInitiated CoverageHold ➝ Hold$17.00Low
3/7/2019UBS GroupInitiated CoverageBuy$22.00Medium
3/6/2019Morgan StanleyDowngradeOverweight ➝ Equal Weight$17.00High
2/20/2019MizuhoDowngradeBuy ➝ Neutral$25.00 ➝ $18.00Medium
2/14/2019Credit Suisse GroupLower Price TargetNeutral ➝ Neutral$26.00 ➝ $20.00Medium
2/14/2019Raymond JamesUpgradeMarket Perform ➝ Outperform$22.00Medium
2/14/2019Maxim GroupReiterated RatingHoldMedium
2/14/2019Wells Fargo & CompanyReiterated RatingHold$24.00 ➝ $20.00Medium
2/11/2019OppenheimerReiterated RatingHoldMedium
2/5/2019Credit Suisse GroupReiterated RatingHold$26.00High
2/5/2019HSBCSet Price TargetSell$12.00High
2/5/2019Bank of AmericaReiterated RatingBuy$24.00Low
1/23/2019Piper Jaffray CompaniesUpgradeUnderweight ➝ Neutral$15.00 ➝ $16.00Low
1/23/2019UBS GroupUpgradeNeutral ➝ BuyLow
1/3/2019Bank of AmericaUpgradeUnderperform ➝ Buy$16.12High
12/13/2018Credit Suisse GroupSet Price TargetHold$26.00Medium
11/7/2018OppenheimerReiterated RatingHoldMedium
11/5/2018Morgan StanleyUpgradeEqual Weight ➝ Overweight$20.00 ➝ $27.00Low
11/2/2018Bank of AmericaBoost Price TargetUnderperform ➝ Underperform$19.00 ➝ $20.00Low
11/2/2018Royal Bank of CanadaSet Price TargetHold$22.00Low
11/2/2018Wells Fargo & CompanyReiterated RatingHoldLow
11/1/2018Maxim GroupReiterated RatingHoldHigh
11/1/2018OppenheimerReiterated RatingHoldHigh
10/17/2018Wells Fargo & CompanySet Price TargetHold$23.00Low
10/17/2018OppenheimerReiterated RatingHoldMedium
10/14/2018Credit Suisse GroupSet Price TargetHold$26.00Medium
10/1/2018The Goldman Sachs GroupUpgradeBuy ➝ Conviction-Buy$30.00High
10/1/2018SVB LeerinkUpgradeUnderperform ➝ Market Perform$16.00 ➝ $24.00High
9/27/2018Wells Fargo & CompanySet Price TargetHold$23.00Low
9/27/2018Cantor FitzgeraldReiterated RatingHold$25.00High
9/21/2018CIBCReiterated RatingMarket Perform ➝ Market PerformLow
9/20/2018OppenheimerReiterated RatingHoldMedium
9/17/2018MizuhoBoost Price TargetBuy$28.00 ➝ $29.00High
9/17/2018Credit Suisse GroupSet Price TargetHold$23.00 ➝ $26.00High
9/17/2018Wells Fargo & CompanySet Price TargetHold$23.00High
9/17/2018BTIG ResearchUpgradeSell ➝ NeutralHigh
9/14/2018Cantor FitzgeraldSet Price TargetHold$25.00Low
9/7/2018Credit Suisse GroupDowngradeOutperform ➝ Neutral$25.00 ➝ $23.00Low
8/24/2018MizuhoReiterated RatingBuy$28.00Low
8/16/2018MizuhoReiterated RatingBuy$28.00High
8/16/2018Cantor FitzgeraldReiterated RatingHold$25.00High
8/3/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$19.00 ➝ $20.00Medium
8/3/2018Jefferies Financial GroupReiterated RatingHold$21.00Medium
8/2/2018BarclaysSet Price TargetEqual Weight ➝ Hold$20.00 ➝ $23.00Medium
8/2/2018Cantor FitzgeraldSet Price TargetHold$25.00Medium
8/2/2018OppenheimerReiterated RatingHoldMedium
8/2/2018MizuhoReiterated RatingBuy$27.00High
8/2/2018Wells Fargo & CompanySet Price TargetHold$23.00Medium
7/31/2018Royal Bank of CanadaReiterated RatingHold$19.00Medium
7/19/2018Cantor FitzgeraldSet Price TargetHold$25.00Medium
7/13/2018Cantor FitzgeraldSet Price TargetNeutral ➝ Hold$18.00 ➝ $25.00Low
6/27/2018CitigroupBoost Price TargetBuy$25.00 ➝ $27.00Medium
6/25/2018The Goldman Sachs GroupBoost Price TargetBuy$25.00 ➝ $28.00Medium
6/18/2018Wells Fargo & CompanyUpgradeUnderperform ➝ Market PerformMedium
5/31/2018CitigroupSet Price TargetBuy ➝ Buy$24.00 ➝ $25.00Low
5/24/2018BarclaysSet Price TargetEqual Weight ➝ Hold$13.00 ➝ $20.00Medium
5/17/2018Cantor FitzgeraldSet Price TargetHold$18.00Low
5/14/2018Credit Suisse GroupSet Price TargetBuy$23.00Low
5/7/2018OppenheimerReiterated RatingHoldLow
5/7/2018Morgan StanleyReiterated RatingEqual Weight ➝ Hold$18.00Low
5/3/2018Cantor FitzgeraldSet Price TargetHold$18.00Low
5/3/2018Maxim GroupReiterated RatingHoldLow
4/22/2018Wells Fargo & CompanySet Price TargetSell$17.00Low
4/20/2018MizuhoReiterated RatingBuy$27.00Low
4/4/2018Credit Suisse GroupSet Price TargetBuy$23.00High
3/26/2018Royal Bank of CanadaReiterated RatingHold$16.00Low
3/20/2018Jefferies Financial GroupInitiated CoverageHold ➝ Hold$19.00Medium
3/1/2018Maxim GroupReiterated RatingHoldMedium
2/13/2018Wells Fargo & CompanyReiterated RatingSellMedium
2/11/2018Credit Suisse GroupUpgradeNeutral ➝ Outperform$20.00 ➝ $23.00Medium
2/9/2018Bank of AmericaLower Price TargetUnderperform ➝ Underperform$17.00 ➝ $16.00Low
2/9/2018SVB LeerinkLower Price TargetUnderweight ➝ Underperform$17.00 ➝ $16.00High
2/9/2018Deutsche Bank AktiengesellschaftLower Price TargetHold ➝ Hold$20.00 ➝ $18.00Medium
2/9/2018GabelliDowngradeBuy ➝ Hold$19.00Medium
2/9/2018Piper Jaffray CompaniesDowngradeNeutral ➝ Underweight$11.00Medium
2/9/2018Royal Bank of CanadaUpgradeUnderperform ➝ Sector Perform$18.00Medium
2/8/2018Cantor FitzgeraldSet Price TargetHold$18.00Medium
2/8/2018OppenheimerReiterated RatingHoldMedium
2/8/2018Maxim GroupReiterated RatingHoldMedium
2/2/2018BTIG ResearchDowngradeNeutral ➝ Sell$17.00Low
1/30/2018Royal Bank of CanadaSet Price TargetSell$13.00Low
1/26/2018SVB LeerinkBoost Price TargetUnderperform$15.00 ➝ $17.00Low
1/25/2018Susquehanna BancsharesReiterated RatingPositive ➝ Positive$22.00 ➝ $24.00Medium
1/24/2018Royal Bank of CanadaSet Price TargetSell$13.00Low
1/23/2018OppenheimerReiterated RatingHoldLow
1/22/2018Credit Suisse GroupSet Price TargetHold$20.00Low
1/22/2018Maxim GroupReiterated RatingHoldLow
1/22/2018Wells Fargo & CompanyReiterated RatingSellLow
1/18/2018BTIG ResearchDowngradeBuy ➝ Neutral$24.00Low
1/11/2018The Goldman Sachs GroupBoost Price TargetBuy$20.00 ➝ $25.00High
1/9/2018MizuhoUpgradeNeutral ➝ Buy$19.12 ➝ $23.00N/A
1/5/2018Wells Fargo & CompanyDowngradeMarket Perform ➝ Underperform$19.58 ➝ $17.00Low
1/4/2018CitigroupUpgradeNeutral ➝ Buy$24.00Low
1/3/2018Cantor FitzgeraldSet Price TargetHold$18.00Medium
1/2/2018SVB LeerinkInitiated CoverageUnderperform ➝ Underperform$15.00Medium
12/28/2017Cantor FitzgeraldSet Price TargetHold$18.00Low
12/18/2017UBS GroupSet Price TargetHold$12.00 ➝ $20.00Low
12/15/2017Royal Bank of CanadaSet Price TargetSell$13.00Low
12/15/2017Deutsche Bank AktiengesellschaftSet Price TargetHold$20.00Medium
12/15/2017Credit Suisse GroupUpgradeUnderperform ➝ Neutral$8.00 ➝ $20.00Medium
12/15/2017Morgan StanleyUpgradeUnderweight ➝ Equal Weight$18.00Medium
12/15/2017BTIG ResearchBoost Price Target$20.00High
12/15/2017The Goldman Sachs GroupUpgradeNeutral ➝ Buy$20.00High
12/14/2017Wells Fargo & CompanyReiterated RatingHoldHigh
12/14/2017Piper Jaffray CompaniesSet Price TargetHold$16.00High
12/14/2017OppenheimerReiterated RatingHoldHigh
12/14/2017Cantor FitzgeraldSet Price TargetHold$10.00High
12/12/2017GuggenheimInitiated CoverageNeutral ➝ Neutral$16.00High
11/29/2017Royal Bank of CanadaSet Price TargetSell$11.00Low
11/29/2017MizuhoBoost Price TargetNeutral ➝ Neutral$12.00 ➝ $16.00Medium
11/28/2017BTIG ResearchSet Price TargetBuy$16.00Low
11/27/2017Cantor FitzgeraldSet Price TargetHold$10.00High
11/25/2017Wells Fargo & CompanyReiterated RatingHoldHigh
11/17/2017MizuhoReiterated RatingNeutral ➝ Neutral$15.00 ➝ $12.00N/A
11/14/2017Cantor FitzgeraldSet Price TargetHold$10.00N/A
11/13/2017JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$11.48 ➝ $11.00N/A
11/12/2017OppenheimerReiterated RatingHoldN/A
11/6/2017Susquehanna BancsharesLower Price TargetPositive ➝ Positive$20.00 ➝ $14.00N/A
11/6/2017Credit Suisse GroupReiterated RatingUnderperform$14.00 ➝ $8.00N/A
11/5/2017Royal Bank of CanadaBoost Price TargetUnderperform$8.00 ➝ $13.00N/A
11/3/2017Piper Jaffray CompaniesReiterated RatingHold$12.00N/A
11/3/2017Morgan StanleyLower Price TargetUnderweight$14.00 ➝ $7.00N/A
11/3/2017Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$14.00N/A
11/2/2017Wells Fargo & CompanyDowngradeMarket Perform$17.00 ➝ $11.36N/A
10/30/2017MizuhoReiterated RatingHold$15.00N/A
10/30/2017Royal Bank of CanadaReiterated RatingUnderperform ➝ Underperform$15.00 ➝ $13.00N/A
10/26/2017Cantor FitzgeraldSet Price TargetHold$17.00N/A
10/25/2017Evercore ISISet Price TargetBuy$38.00N/A
10/20/2017Royal Bank of CanadaSet Price TargetSell$15.00N/A
10/20/2017BarclaysSet Price TargetHold$21.00 ➝ $19.00N/A
10/19/2017Cantor FitzgeraldSet Price TargetHold$17.00N/A
10/6/2017Piper Jaffray CompaniesSet Price TargetHold$23.00N/A
10/5/2017Morgan StanleySet Price TargetUnderweight$16.00 ➝ $15.00N/A
10/5/2017Wells Fargo & CompanyReiterated RatingMarket PerformN/A
10/4/2017Wells Fargo & CompanySet Price TargetHold$20.00N/A
10/4/2017CowenReiterated RatingMarket Perform$30.00 ➝ $18.00N/A
10/4/2017Maxim GroupReiterated RatingHoldN/A
10/4/2017OppenheimerReiterated RatingHoldMedium
10/4/2017MizuhoReiterated RatingHold$16.00Medium
10/4/2017BarclaysSet Price TargetEqual Weight$23.00 ➝ $21.00Medium
10/4/2017BTIG ResearchReiterated RatingBuy$24.00Medium
10/2/2017Cantor FitzgeraldSet Price TargetHold$17.00Low
9/21/2017Sanford C. BernsteinLower Price TargetMkt Perform ➝ Market Perform$28.00 ➝ $20.00Low
9/18/2017Cantor FitzgeraldReiterated RatingHold$17.00Low
9/18/2017Royal Bank of CanadaLower Price TargetUnderperform$21.00 ➝ $15.00High
9/14/2017Maxim GroupReiterated RatingHold$15.50Low
9/14/2017UBS GroupReiterated RatingNeutral$19.00Low
9/13/2017GabelliReiterated RatingBuyLow
9/12/2017Jefferies Financial GroupLower Price TargetHold$21.00 ➝ $18.50High
9/11/2017OppenheimerReiterated RatingHoldLow
9/11/2017Cantor FitzgeraldSet Price TargetHold$27.00 ➝ $17.00High
9/11/2017BTIG ResearchUpgradeNeutral ➝ Buy$24.00High
9/6/2017JMP SecuritiesBoost Price TargetUnderperform$13.00 ➝ $14.00Low
9/5/2017Royal Bank of CanadaReiterated RatingUnderperformMedium
9/5/2017Cantor FitzgeraldReiterated RatingNeutral$27.00High
8/31/2017The Goldman Sachs GroupReiterated RatingNeutral$28.00 ➝ $21.00Low
8/30/2017Cantor FitzgeraldReiterated RatingHold$27.00Low
8/23/2017Credit Suisse GroupDowngradeNeutral ➝ Underperform$25.00 ➝ $13.00Medium
8/22/2017MizuhoReiterated RatingNeutral$30.00 ➝ $16.00Low
8/16/2017CitigroupDowngradeBuy ➝ Neutral$32.00 ➝ $19.00Medium
8/9/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$43.00 ➝ $28.00High
8/9/2017Jefferies Financial GroupReiterated RatingHold$33.00 ➝ $26.00Medium
8/9/2017Cantor FitzgeraldReiterated RatingNeutral$31.00 ➝ $27.00High
8/9/2017Credit Suisse GroupReiterated RatingOutperform$39.00High
8/7/2017BarclaysLower Price TargetEqual Weight$38.00 ➝ $23.00High
8/4/2017Piper Jaffray CompaniesReiterated RatingNeutral$28.00 ➝ $23.00High
8/4/2017Sanford C. BernsteinDowngradeOutperform ➝ Market Perform$42.00 ➝ $28.00High
8/4/2017Maxim GroupReiterated RatingHold$35.00High
8/4/2017CowenDowngradeOutperform ➝ Market Perform$50.00 ➝ $30.00High
8/4/2017Credit Suisse GroupDowngradeOutperform ➝ Neutral$39.00 ➝ $25.00High
8/4/2017Royal Bank of CanadaDowngradeOutperform ➝ Underperform$37.00 ➝ $21.00N/A
8/3/2017Cantor FitzgeraldSet Price TargetHold$27.00High
8/3/2017CIBCReiterated RatingOutperform ➝ Market PerformHigh
8/3/2017UBS GroupDowngradeOutperform ➝ Market PerformHigh
8/3/2017Credit Suisse GroupSet Price TargetBuy$39.00High
8/3/2017OppenheimerDowngradeOutperform ➝ Market Perform$41.00High
8/2/2017MizuhoReiterated RatingHold$30.00High
7/25/2017Jefferies Financial GroupReiterated RatingNeutral ➝ HoldLow
7/18/2017OppenheimerReiterated RatingOutperform$41.00Low
7/17/2017Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$38.00 ➝ $37.00Low
7/13/2017Maxim GroupReiterated RatingHold$35.00High
(Data available from 7/6/2017 forward)

News Sentiment Rating

-0.30 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 6 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
  • 4 very positive mentions
  • 20 positive mentions
  • 5 negative mentions
  • 4 very negative mentions
  • 3 very positive mentions
  • 0 positive mentions
  • 2 negative mentions
  • 2 very negative mentions
  • 5 very positive mentions
  • 11 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
  • 7 very positive mentions
  • 16 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
  • 6 very positive mentions
  • 8 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
  • 8 very positive mentions
  • 15 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
  • 1 very positive mentions
  • 6 positive mentions
  • 4 negative mentions
  • 2 very negative mentions

Current Sentiment

  • 1 very positive mentions
  • 6 positive mentions
  • 4 negative mentions
  • 2 very negative mentions
Teva Pharmaceutical Industries logo
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.
Read More

Today's Range

Now: $7.71
Low: $7.55
High: $7.76

50 Day Range

MA: $8.26
Low: $7.38
High: $9.52

52 Week Range

Now: $7.71
Low: $7.23
High: $10.50


7,611,371 shs

Average Volume

9,384,305 shs

Market Capitalization

$8.51 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of Teva Pharmaceutical Industries?

The following sell-side analysts have issued research reports on Teva Pharmaceutical Industries in the last year: Argus, Bank of America Co., Barclays PLC, Piper Sandler, Raymond James, Sanford C. Bernstein, StockNews.com, TheStreet, UBS Group AG, and Wells Fargo & Company.
View the latest analyst ratings for TEVA.

What is the current price target for Teva Pharmaceutical Industries?

0 Wall Street analysts have set twelve-month price targets for Teva Pharmaceutical Industries in the last year. Their average twelve-month price target is $10.71, suggesting a possible upside of 39.0%.
View the latest price targets for TEVA.

What is the current consensus analyst rating for Teva Pharmaceutical Industries?

Teva Pharmaceutical Industries currently has 1 sell rating, 5 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in TEVA, but not buy more shares or sell existing shares.
View the latest ratings for TEVA.

How do I contact Teva Pharmaceutical Industries' investor relations team?

Teva Pharmaceutical Industries' physical mailing address is 5 BAZEL ST P O B 3190, PETACH TIKVA L3, 49131. The company's listed phone number is (723) 914-8213 and its investor relations email address is [email protected] The official website for Teva Pharmaceutical Industries is www.tevapharm.com. Learn More about contacing Teva Pharmaceutical Industries investor relations.